NASDAQ: PYPD
Polypid Ltd Stock Ownership - Who owns Polypid?

Insider buying vs selling

Have Polypid Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PYPD insiders and whales buy or sell their stock.

PYPD Shareholders

What type of owners hold Polypid Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aigh Capital Management LLC7.63%1,194,108$4.57MInstitution
Rosalind Advisors Inc6.23%975,462$3.74MInstitution
Dafna Capital Management LLC1.33%207,900$796.26kInstitution
J Goldman Co LP1.27%199,310$763.36kInstitution
Adar1 Capital Management LLC0.66%103,950$398.13kInstitution
Morgan Stanley0.50%77,590$297.17kInstitution
Symmetry Peak Management LLC0.41%63,950$244.93kInstitution
Lumbard Kellner LLC0.24%38,200$146.31kInstitution
Citadel Advisors LLC0.08%13,151$50.37kInstitution
Steward Partners Investment Advisory LLC0.05%7,346$28.14kInstitution

1 of 2

PYPD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYPD18.47%0.00%
HOWL40.55%59.45%Net SellingNet Selling
OSTX1.89%20.70%Net Selling
CUE22.58%7.36%Net Buying
NRXP5.67%94.33%Net Buying

Polypid Stock Ownership FAQ

Who owns Polypid?

Polypid (NASDAQ: PYPD) is owned by 18.47% institutional shareholders, 0.00% Polypid insiders, and 81.53% retail investors. Aigh Capital Management LLC is the largest individual Polypid shareholder, owning 1.19M shares representing 7.63% of the company. Aigh Capital Management LLC's Polypid shares are currently valued at $4.57M.

If you're new to stock investing, here's how to buy Polypid stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.